Acasă
В период пандемии COVID-19 крайне необходимо особое внимание для обеспечения беспрерывной профилактики, диагностики, ухода и лечения туберкулеза.
The non-governmental organization "New Vector" has presented the results of the communities, rights and gender (CRG) assessment. It was carried out wi ..
Today, Elchin Mukhtarli, head of “Saglamliga Khidmat” Public Union and Chingiz Ramazanli, head of “Towards TB Free Future” patient organization, has m ..
The Stop TB Partnership and the Foundation for Innovative New Diagnostics (FIND) today launched an online resource center of computer-aided detection ..
On July 6, 2020, in response to numerous protests and protests by community activists, Johnson&Johnson Pharmaceutical Corporation announced a price re ..
The unique international platform Global TB Caucus is a key partner of TB REP 2.0 in building dialogue at the parliamentary level in the countries of ..
COVID-19 demonstrates how vulnerable people with lung diseases can be, and also makes obvious the urgent need to improve quality and strengthened peop ..
On June 3, a special #OneImpact webinar: Monitoring and Accountability of the Community in the Response to TB & COVID-19 took place. During the webin ..
In the context of the exceptional international situation created by the COVID-19 pandemic and the restrictions set in place by many countries in the ..
The COVID-19 epidemic, which has affected the majority of countries of the world, requires a quick response, especially when it comes to those who are ..
Several TB-REP 2.0 programme member countries showed interest in introducing the OneImpact platform in their countries. The platform was developed, in ..
One of the leading activities of the World Health Organization Regional Office for Europe (WHO/Europe) as a partner of the TB-REP 2.0 programme is to ..
In 2018, PAS Center together with implementing partners have designed a new regional project (TB-REP 2.0) to advance towards people-centered approaches ensuring provision of quality TB and DR-TB care and prevention in EECA region, based on previous experience and lessons learned from the implementation of the regional TB-REP program designed to contribute to strengthening health systems’ responses to TB in the longer term. The overall goal of TB-REP 2.0 is to foster timely TB case detection and improved treatment outcomes in patients with special emphasis on drug-resistant TB, in eleven EECA countries through meaningful involvement of communities and civil society and integrated people-centered TB care delivery systems able to address the needs of key and vulnerable populations. The program incorporates the full spectrum of DR-TB prevention and care issues, targeting both health and sustainable community systems for improved quality and strengthened people-centered approaches in TB care delivery.
The project is funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria
